Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2015

Feb 3, 2015

29745_dirs_2015-02-03_30904aaf-1835-49b5-b8b8-6c93e2c635ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2015-02-01

Reporting Person: Simmons Jeffrey N (SVP&Pres. Elanco Animal Health)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-01 Common Stock M 12591 Acquired 119680 Direct
2015-02-01 Common Stock F 5824 $72 Disposed 113856 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-01 Restricted Stock Unit $ M 12591 Disposed 2015-02-01 Common Stock (12591.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 995 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.